Content on this webpage is provided for historical information about the NIH Clinical Center. Content is not updated after the listed publication date and may include information about programs or activities that have since been discontinued.
The National Cancer Institute is looking for clinical trial participants with Glypican-3 positive HHC, a type of liver cancer, to receive an experimental therapy of genetically modified CAR-T cells. Study treatment consists of a preparative regimen with standard chemotherapy drugs fludarabine and cyclophosphamide and CAR-T cell infusion. Researchers want to see if this treatment can help people with a certain type of liver cancer. NIH will cover study-related costs for medical care, travel and housing. For more information on specific inclusion and exclusion criteria, visit https://go.usa.gov/xtErY or call 866-444-2214 (TTY users dial 7-1-1) and reference study #21-C-0030.
Are you interested in participating in research as a healthy volunteer? Willing to undergo a bronchoscopy to help advance tuberculosis (TB) research? The National Heart, Lung, and Blood Institute (NHLBI) is conducting a study to evaluate airway immunity in adults with a positive or negative TB skin test. Want to participate? Contact our NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1) or ccopr@nih.gov or visit https://go.usa.gov/xM4mH. Refer to study number 21-H-0027.
NIAID researchers are enrolling healthy volunteers 18-29 living in the DC, Maryland and Virginia areas in an investigational Epstein-Barr virus (EBV) vaccine clinical trial. If you are eligible, consider joining to help research into stopping the spread of EBV – the most common cause of infectious mononucleosis (mono) and associated with some cancers. For more information contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1), ccopr@nih.gov or visit https://go.usa.gov/xsYK5. Refer to study #21-I-0005.
